Del Mar, CA, United States of America

Jerry Anchin



Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Insights into the Innovations of Jerry Anchin

Introduction

Jerry Anchin, an accomplished inventor based in Del Mar, California, has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work primarily focuses on the modulation of macrophage migration inhibitory factor (MIF), which plays a crucial role in various pathological conditions.

Latest Patents

Anchin's latest patents include a revolutionary method for screening agents that modulate the activity of macrophage migration inhibitory factor. The inhibitors he developed provide promising utility in treating a variety of disorders associated with MIF activity. These innovative compounds include stereoisomers, prodrugs, and pharmaceutically acceptable salts. Furthermore, his patents include compositions that combine MIF inhibitors with suitable pharmaceutical carriers, alongside methods for their application in medical treatments.

Career Highlights

Throughout his career, Jerry Anchin has been affiliated with prominent companies focusing on pharmaceutical innovations. Notably, he has contributed to the work done at Avanir Pharmaceuticals, where he leveraged his expertise in developing therapies related to MIF. His inventions demonstrate both creativity and a strong understanding of the complexities involved in pharmaceutical development.

Collaborations

Jerry Anchin has collaborated with esteemed professionals in the industry, including Federico C. A. Gaeta and Andrew J. Baird. These partnerships have been pivotal in advancing his research and furthering the impact of his patents in the pharmaceutical landscape.

Conclusion

In conclusion, Jerry Anchin's innovative solutions in modulating macrophage migration inhibitory factor illustrate his dedication to enhancing therapeutic options for various medical conditions. His extensive patent portfolio and collaborative efforts position him as a noteworthy figure in pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…